GENCODE: comprehensive genome annotation for human and mouse
GENCODE:人类和小鼠的全面基因组注释
基本信息
- 批准号:9980954
- 负责人:
- 金额:$ 222.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2021-09-13
- 项目状态:已结题
- 来源:
- 关键词:AffectAlternative SplicingBiologicalBiomedical ResearchClassificationClinicalCodeCommunitiesComplementary DNAComputing MethodologiesDataData SetDiseaseEnhancersEnsureExpressed Sequence TagsFoundationsGenesGenetic TranscriptionGenomeGenomic approachGenomicsGenotype-Tissue Expression ProjectGoalsGraphHaplotypesHealthHumanHuman GenomeIndividualInformaticsInvestigationKnock-outKnowledgeLengthManualsMass Spectrum AnalysisMethodsModelingMouse StrainsMusNucleic Acid Regulatory SequencesPilot ProjectsPolymerasePopulationProtein IsoformsProteinsPseudogenesPublic HealthQuality ControlRNAResearchResearch DesignSeriesSourceTechnologyTissuesTranscriptTranscription InitiationUntranslated RNAValidationbaseepigenomeevidence basegenome annotationgenome browsermouse genomenew technologynovelpopulation basedrecruitreference genometooltranscriptometranscriptome sequencingtranscriptomicsweb site
项目摘要
OVERALL - PROJECT SUMMARY
The objective of the GENCODE consortium is to create a foundational reference genome
annotation, in which all gene features in the human and mouse genomes are identified and
classified with high accuracy based on biological evidence, and then to release these
annotations for the benefit of biomedical research and genome interpretation. GENCODE aims
for a better understanding of a `normal' human genome; using genome sequences of the most
commonly used mouse strains will facilitate the most effective use of these key models for
large-scale knockout analysis and disease-specific research. To produce regular annotation
releases of high accuracy, GENCODE will continue to follow its well-established and
conservative research design, supplemented by targeted investigations into the value of new
technologies, new data and new sources of evidence. GENCODE focuses on protein-coding
and non-coding loci, including their alternatively spliced isoforms and pseudogenes. Over the
course of this proposal GENCODE will follow major directions in genomics, including graph-
based genome representations, long-read transcriptome sequencing, connecting genes and the
associated regulatory regions that affect their transcription, and identifying genes that are not
present on the current reference assembly. The GENCODE consortium has four fundamental
components: (1) a comprehensive gene annotation pipeline leveraging manual annotation; (2)
an integrated approach to pseudogene identification and classification; (3) a set of
computational methods to evaluate and enhance gene annotation; and (4) complementary
experimental pipelines for validation and functional annotation. More specifically, in the next four
years GENCODE aims to (1) extend the human and mouse GENCODE gene sets to as near
completion as possible given current experimental technology; (2) deploy population-based
genome annotation to ensure that any transcript isoform expressed in an individual human will
be present in the reference annotation set; (3) extend the gene annotation to include core
regulatory regions and tissue-specific enhancers from selected datasets; (4) to distribute
GENCODE annotations and engage with community annotation efforts. Current popular
distribution channels for GENCODE data including the GENCODE web site, the Ensembl and
UCSC Genome Browsers, will be maintained. Finally, new mechanisms for prioritizing genes for
manual annotation with community input will be established, with the long-term aim of
establishing GENCODE as the standard annotation set for research and clinical genomics
efforts.
总体 - 项目摘要
Gencode联盟的目的是创建基础参考基因组
注释,其中所有基因在人和小鼠基因组中的特征都被鉴定出来,并且
根据生物学证据,以高精度分类,然后释放这些
为生物医学研究和基因组解释的益处的注释。 Gencode的目标
为了更好地理解“正常”人类基因组;使用最多的基因组序列
常用的小鼠菌株将有助于最有效地使用这些关键模型
大规模敲除分析和疾病特异性研究。产生常规注释
Gencode的发行精度很高,将继续遵循其良好的公认和
保守研究设计,以针对新的价值进行针对性的研究补充
技术,新数据和新证据来源。 Gencode专注于蛋白质编码
和非编码基因座,包括其剪接的同工型和假基因。在
该提案Gencode的过程将遵循基因组学的主要方向,包括图形
基于基因组表示,长阅读转录组测序,连接基因和
影响其转录的相关调节区域,并识别不是
存在当前参考组件上。 Gencode财团有四个基本
组件:(1)综合基因注释管道利用手动注释; (2)
用于鉴定和分类的综合方法; (3)一组
评估和增强基因注释的计算方法; (4)补充
实验管道验证和功能注释。更具体地说,在接下来的四个
年Gencode年的旨在(1)将人和小鼠Gencode基因设置扩展到附近
鉴于当前的实验技术,尽可能完成; (2)部署基于人群的
基因组注释,以确保在人类意愿中表达的任何转录本同工型
存在于参考注释集中; (3)将基因注释扩展到包括核心
来自选定数据集的调节区域和组织特异性增强子; (4)分发
Gencode注释并参与社区注释工作。当前流行
Gencode数据的分发渠道,包括Gencode网站,Ensembl和
UCSC基因组浏览器将得到维护。最后,用于优先基因的新机制
将建立与社区意见的手动注释,以长期的目标
建立Gencode作为研究和临床基因组学的标准注释集
努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Flicek其他文献
Paul Flicek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Flicek', 18)}}的其他基金
The WashU-UCSC-EBI Human Genome Reference Center."
华盛顿大学-UCSC-EBI 人类基因组参考中心。”
- 批准号:
10419218 - 财政年份:2021
- 资助金额:
$ 222.7万 - 项目类别:
The WashU-UCSC-EBI Human Genome Reference Center
华盛顿大学-UCSC-EBI 人类基因组参考中心
- 批准号:
10219322 - 财政年份:2019
- 资助金额:
$ 222.7万 - 项目类别:
The WashU-UCSC-EBI Human Genome Reference Center
华盛顿大学-UCSC-EBI 人类基因组参考中心
- 批准号:
10020425 - 财政年份:2019
- 资助金额:
$ 222.7万 - 项目类别:
The WashU-UCSC-EBI Human Genome Reference Center
华盛顿大学-UCSC-EBI 人类基因组参考中心
- 批准号:
9906005 - 财政年份:2019
- 资助金额:
$ 222.7万 - 项目类别:
GENCODE: comprehensive reference genome annotation for human and mouse
GENCODE:人类和小鼠的综合参考基因组注释
- 批准号:
10186568 - 财政年份:2013
- 资助金额:
$ 222.7万 - 项目类别:
GENCODE: comprehensive genome annotation for human and mouse
GENCODE:人类和小鼠的全面基因组注释
- 批准号:
9277658 - 财政年份:2013
- 资助金额:
$ 222.7万 - 项目类别:
相似国自然基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
- 批准号:82372743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
MEK/ERK通路对Bim选择性剪接的调节及其在胃癌细胞对化疗敏感性中作用
- 批准号:81071809
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
- 批准号:30971223
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 222.7万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 222.7万 - 项目类别:
Illuminating multiplexed RNA dynamics to interrogate splicing in health and disease
阐明多重 RNA 动力学以探究健康和疾病中的剪接
- 批准号:
10713923 - 财政年份:2023
- 资助金额:
$ 222.7万 - 项目类别:
Investigate Host Gene Isoforms Contributing to HIV Persistence in Cocaine Users
研究导致可卡因吸食者中艾滋病毒持续存在的宿主基因亚型
- 批准号:
10788990 - 财政年份:2023
- 资助金额:
$ 222.7万 - 项目类别:
Role of RNA helicase Ddx5 in pathological cardiac remodeling
RNA解旋酶Ddx5在病理性心脏重塑中的作用
- 批准号:
10718560 - 财政年份:2023
- 资助金额:
$ 222.7万 - 项目类别: